Analgesics in the United Kingdom

Analgesics in the United Kingdom
Analgesics is recording another strong year of current value growth in 2023, albeit at a slower rate than in 2022. Growth is particularly dynamic in the paediatric segment, especially for acetaminophen and ibuprofen, driven by the outbreak of Streptococcus A (Strep A) in schools, which began in Q4 2022, and continued into Q1 2023. Upturn in demand for paediatric analgesics has also been aided by strong consumer loyalty towards branded products, as parents are generally more concerned about their...

Euromonitor International's Analgesics in United Kingdom report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.